| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.4M | -92.0% |
| R&D Expense | $118.0M | -34.8% |
| SG&A Expense | $37.8M | -6.6% |
| Operating Income | -$151.5M | +8.9% |
| Pre-tax Income | -$142.4M | +12.5% |
| Net Income | -$142.4M | +12.5% |
| EPS (Basic) | -$1.73 | +14.8% |
| EPS (Diluted) | -$1.73 | +14.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.8M | -24.0% |
| Short-term Investments | $88.4M | -55.4% |
| Current Assets | $156.4M | -45.8% |
| Total Assets | $168.9M | -45.1% |
| Current Liabilities | $20.1M | -58.0% |
| Total Liabilities | $20.2M | -57.7% |
| Stockholders' Equity | $148.6M | -42.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$132.2M | +8.5% |
| Investing Cash Flow | $114.3M | +698.0% |
| Financing Cash Flow | $1.8M | -96.7% |